Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Global Biotechnology Instruments Market Size to Hit US$ 80,051.1 Million by 2026, with a CAGR of 12.66% Growth - Study by Facts & Factors

[171+ Pages Research Study] According to a market research study published by Facts and Factors, the demand analysis of Global Biotechnology Instruments Market size & share revenue was estimated at approximately USD 41,006.2 Million in 2020 and is expected to reach revenue of around USD 80,051.1 Million by the end of 2026, growing at a CAGR of around 12.66% between 2021 and 2026. The key market players are listed in the report with their sales, revenues and strategies are Agilent Technologies, Becton Dickinson, and Company, Abbott, Alcon Inc., AngioDynamics, Bio-Rad Laboratories, BioMerieux SA, BioTek Instruments Inc., Cynosure LLC, Candela Medical, Endress+Hauser (Analytik Jena GmbH), Danaher Corporation, IIlumina Inc., F. Hoffmann-La Roche Ltd., IRIDEX, Merck KGaA, Lumenis, Perkin Elmer Inc., Novanta Inc., Siemens Healthineers, QIAGEN, Waters Corporation, Tecan Group AG, Zimmer Mediz

NEW YORK, United States, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Biotechnology Instruments Market Product (Lab Automation Instruments, Life Science Consumables, IVD Instruments, and Medical Lasers), and End-User (Government & Academic Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Facilities, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026” in its research database.

“According to the latest research study, the demand of global Biotechnology Instruments Market size & share was valued at approximately USD 41,006.2 Million in 2020 and is likely to grow at a CAGR of 12.66% and is anticipated to reach around USD 80,051.1 Million by 2026.”

Report Overview:

Bioinstrumentation refers to the use of biomedical engineering that is focusing on the devices and mechanics, which are used in measuring, evaluating, and treating biological systems. The biotechnology instruments market across the globe has witnessed major growth in recent years, mostly due to the immense increase in demand for biotechnology products for the making of personalized medicine.

Such a promising field of medicine that aims to serve consumers via medicines produced by keeping in mind every individual’s biological makeup and getting rid of the negative effects, which might result from mass-produced medicines, is likely to be one of the key customers of biotechnology products in the forthcoming years. Moreover, the growing use of 2D and 3D cell cultures in the area of discovery and manufacture of novel drug compounds is emerging as a major aspect propelling the global biotechnology instruments market expansion.